How to generate success in commercialization of biopharma in an age of uncertainty
Come meet and engage directly with leading expert Joff Masukawa, Diligentia Strategies. With over 20 years of healthcare and life science experience, Joff has led and executed numerous commercial strategies for biopharmacetuicals, cell therapies, diagnostics, and novel technologies.
Joff will also bring to the table a unique niche focus of rare disease orphan drug and specialty products that demand high price. He will discuss key stakeholders points of view and valuable points for reimbursement.